A randomized, double-blind, placebo-controlled, parallel-group, multi-center trial of pregabalin versus placebo in the treatment of neuropathic pain associated with diabetic peripheral neuropathy
Phase of Trial: Phase III
Latest Information Update: 20 Aug 2007
At a glance
- Drugs Pregabalin (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 20 Aug 2007 Status changed from in progress to completed.
- 18 Dec 2005 New trial record.